3
Table 6. Hypertension
Recommendations
COR LOE
Regular BP screening and appropriate treatment of patients with
hypertension, including lifestyle modification and pharmacological
therapy, are recommended.
I A
Annual screening for high BP and health-promoting lifestyle
modification are recommended for patients with prehypertension
(SBP of 120-139 mm Hg or DBP of 80-89 mm Hg ).
I A
Patients who have hypertension should be treated with
antihypertensive drugs to a target BP of <140/90 mm Hg.
I A
Successful reduction of BP is more important in reducing stroke
risk than the choice of a specific agent, and treatment should be
individualized on the basis of other patient characteristics and
medication tolerance.
I A
Self-measured BP monitoring is recommended to improve BP
control.
I A
Table 7. Obesity and Body Fat Distribution
Recommendations
COR LOE
Among overweight (BMI=25-29 kg/m
2
) and obese (BMI >30 kg/m
2
)
individuals, weight reduction is recommended for lowering BP.
I A
Among overweight (BMI=25-29 kg/m
2
) and obese (BMI >30 kg/m
2
)
individuals, weight reduction is recommended for reducing the risk
of stroke.
I B
Table 8. Diabetes
Recommendations
COR LOE
Control of BP in accordance with an AHA/ACC/CDC Advisory to
a target of <140/90 mm Hg is recommended in patients with type 1
or type 2 diabetes mellitus.
I A
Treatment of adults with diabetes mellitus with a statin, especially
those with additional risk factors, is recommended to lower the risk
of first stroke.
I A
e usefulness of aspirin for primary stroke prevention for patients
with diabetes mellitus but low 10-year risk of CVD is unclear.
IIb B
Adding a fibrate to a statin in people with diabetes mellitus is NOT
useful for decreasing stroke risk.
III B
